
|Videos|March 30, 2021
Examining TKI Combinations in Advanced RCC
A panel discusses the role of TKI combination therapies for patients with advanced renal cell carcinoma and how they have changed the treatment landscape.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ESMO 2025 Poll Results: Most Anticipated GU Cancer Abstracts
2
Cancer Antigen mRNA-4359 Shows Increased Efficacy in Patients with Melanoma
3
Immunotherapy EO2463 Receives FDA Fast Track for Follicular Lymphoma
4
Policy Meets Prognosis: Medicaid Expansion Related to Long-Term Cancer Survival
5